These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33851441)

  • 1. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
    Bi D; Liu M; Lin J; Liu R
    Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian borrowing from historical control data in a vaccine efficacy trial.
    Peng L; Jin J; Chambonneau L; Zhao X; Zhang J
    Pharm Stat; 2023; 22(5):815-835. PubMed ID: 37226586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
    Warren JL; Wang Q; Ciarleglio MM
    Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covariate adjusted meta-analytic predictive (CA-MAP) prior for historical borrowing using patient-level data.
    Hupf B; Yang Y; Gryder R; Bunn V; Lin J
    J Biopharm Stat; 2024 Apr; ():1-9. PubMed ID: 38562017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian adaptive design for covariate-adaptive historical control information borrowing.
    Jin H; Kim MO; Scheffler A; Jiang F
    Stat Med; 2023 Dec; 42(29):5338-5352. PubMed ID: 37750361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On efficient posterior inference in normalized power prior Bayesian analysis.
    Han Z; Zhang Q; Wang M; Ye K; Chen MH
    Biom J; 2023 Jun; 65(5):e2200194. PubMed ID: 36960489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model-based approach for historical borrowing, with an application to neovascular age-related macular degeneration.
    Brizzi F; Steiert B; Pang H; Diack C; Lomax M; Peck R; Morgan Z; Soubret A
    Stat Methods Med Res; 2023 Jun; 32(6):1064-1081. PubMed ID: 37082812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
    Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
    J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic power prior approach to non-inferiority trials for normal means.
    Mariani F; De Santis F; Gubbiotti S
    Pharm Stat; 2024; 23(2):242-256. PubMed ID: 37964403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust incorporation of historical information with known type I error rate inflation.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseases.
    Sebastien B
    J Pharmacokinet Pharmacodyn; 2023 Dec; 50(6):495-499. PubMed ID: 37148459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling.
    Wei W; Blaha O; Esserman D; Zelterman D; Kane M; Liu R; Lin J
    Stat Med; 2024 May; 43(12):2439-2451. PubMed ID: 38594809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian sample size determination in basket trials borrowing information between subsets.
    Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
    Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of healthy volunteers data on receptor occupancy into a phase II proof-of-concept trial using a Bayesian dynamic borrowing design.
    Di Stefano F; Rodrigues C; Galtier S; Guilleminot S; Robert V; Gasparini M; Saint-Hilary G
    Biom J; 2023 Dec; 65(8):e2200305. PubMed ID: 37888795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The scale transformed power prior for use with historical data from a different outcome model.
    Alt EM; Nifong B; Chen X; Psioda MA; Ibrahim JG
    Stat Med; 2023 Jan; 42(1):1-14. PubMed ID: 36318875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes.
    Fayette L; Sailer MO; Perez-Pitarch A
    CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1386-1397. PubMed ID: 37644910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptively leveraging external data with robust meta-analytical-predictive prior using empirical Bayes.
    Zhang H; Shen Y; Li J; Ye H; Chiang AY
    Pharm Stat; 2023; 22(5):846-860. PubMed ID: 37220997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.